Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department;Poder diagnóstico y pronóstico de los biomarcadores para mejorar el manejo de la neumonía adquirida en la comunidad en los servicios de urgencias

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 32, Issue 4, 2014, Pages 225-235

  Julián Jiménez, Agustín ^a   Timón Zapata, Jesús ^a   Laserna Mendieta, Emilio José ^a   Sicilia Bravo, Isabel ^a   Palomo De Los Reyes, María José ^a   Cabezas Martínez, Ángeles ^a   Laín Terés, Natividad ^a   Estebaran Martín, Josefa ^a   Lozano Ancín, Agustín ^a   Cuena Boy, Rafael ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

Bacteraemia; Biomarkers; C reactive protein; Community acquired pneumonia; Emergency Department; Lactate; Mortality; Pneumonia Severity Index; Pro adrenomedullin; Procalcitonin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LACTIC ACID; MID REGIONAL PRO ADRENOMEDULLIN; PROADRENOMEDULLIN; PROCALCITONIN; UNCLASSIFIED DRUG; UREA;

ARTICLE; BACTEREMIA; BLOOD CULTURE; BLOOD PRESSURE; BREATHING RATE; CHARLSON COMORBIDITY INDEX; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; PNEUMOCOCCAL INFECTION; PNEUMONIA SEVERITY INDEX; PREDICTIVE VALUE; PROGNOSIS; PROGNOSTIC SEVERITY SCALE; PROSPECTIVE STUDY; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; SOCIAL STATUS; AGE; AGED; DISEASE ASSESSMENT; DISEASE SEVERITY; MOLECULAR DIAGNOSIS; PREDICTION; STREPTOCOCCUS PNEUMONIAE; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY TREATMENT; EVALUATION STUDY; FEMALE; MALE; PNEUMONIA, BACTERIAL; TOTAL QUALITY MANAGEMENT;

AGED; BIOLOGICAL MARKERS; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; FEMALE; HUMANS; MALE; PNEUMONIA, BACTERIAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT;

EID: 84898540066     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2013.04.015     Document Type: Article

References (47)

1. A. Julián-Jiménez, F.J. Candel, P. Piñera, J. González del Castillo, M.S. Moya, and M. Martínez Recomendaciones INFURG-SEMES: manejo de la infección respiratoria de vías bajas en urgencias Monografías de Emergencias 3 2009 1 21
2. A. Torres, J. Barberán, M. Falgera, R. Menéndez, J. Molina, and Olaechea et al. Guía multidisciplinar para la valoración pronóstica, diagnóstico y tratamiento de la neumonía adquirida en la comunidad Med Clin (Barc) 140 2013 223e1 223e19
3. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, D. Campbell, and N.C. Dean et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 Suppl 2 2007 S27 S72
4. D. Aujesky, J.B. McCausland, J. Whittle, D. Scott, D.M. Yealy, and M.J. Fine Reasons why emergency department providers do not rely on the Pneumonia Severity Index to determine the initial site of treatment for patients with pneumonia Clin Infect Dis 49 2009 e100 e108
5. A. Julián-Jiménez ¿Cuándo y dónde ingresar las neumonías adquiridas en la comunidad? Emergencias 23 2011 161 163
6. S. Ewig, and A. Torres Community-acquired pneumonia as an emergency: Time for an aggressive intervention to lower mortality Eur Respir J 38 2011 253 260
7. A. Julián-Jiménez, J. González del Castillo, and F.J. Candel González ¿Cuándo, dónde y cómo ingresar al paciente con neumonía adquirida en la comunidad? Rev Clin Esp 213 2013 99 107
8. J. González-Castillo, F.J. Candel, and A. Julián- Jiménez Antibióticos y el factor tiempo en la infección en urgencias Enferm Infecc Microbiol Clin 31 2013 173 180
9. A. Lacoma, C. Prat, and V. Ausina Relevancia de los marcadores de inflamación en el diagnóstico, pronóstico y nuevas formas de tratamiento de las enfermedades infecciosas Enferm Infecc Microbiol Clin 28 2010 263 265
10. P. Tudela, C. Prat, A. Lacoma, J.M. Mòdol, J. Domínguez, and M. Giménez et al. Biomarcadores para la predicción en urgencias de infección bacteriana, bacteriemia y gravedad Emergencias 24 2012 348 356
11. A. Julián-Jiménez, F.J. Candel González, and J. González del Castillo Utilidad de los biomarcadores de inflamación e infección en los servicios de urgencias Enferm Infecc Microbiol Clin 2013 http://dx.doi.org/10.1016/j.eimc.2013.01.005
12. P. Tudela, C. Prat, A. Lacoma, and J.M. Mòdol Biomarcadores y sospecha de infección en los servicios de urgencias Med Clin (Barc) 139 2012 33 37
13. A. Julián-Jiménez Biomarcadores de infección en urgencias: ¿cuáles pueden sernos útiles? Emergencias 24 2012 343 345
14. P. Schuetz, M. Wolbers, M. Christ-Crain, R. Thomann, C. Falconnier, and I. Widmer et al. Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections Critical Care 14 2010 R106
15. R. Menéndez, R. Martínez, S. Reyes, J. Mensa, X. Filella, and M.A. Marcos et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia Thorax 64 2009 587 591
16. A. Lacoma, N. Rodríguez, C. Prat, J. Ruiz-Manzano, F. Andreo, and A. Ramírez et al. Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia Eur J Clin Microbiol Infect Dis 31 2012 825 833
17. M. Christ-Crain, and S.M. Opal Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia Crit Care 14 2010 203
18. M. Falguera, J. Trujillano, S. Caro, R. Menéndez, J. Carratalá, and A. Ruiz-González et al. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia Clin Infect Dis 49 2009 409 416
19. F. Müller, M. Christ-Crain, T. Bregenzer, M. Krause, W. Zimmerli, and B. Mueller et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: A prospective cohort trial Chest 138 2010 121 129
20. S. Krüger, S. Ewig, S. Giersdorf, O. Hartmann, N. Suttorp, T. Welte and the German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia Am J Respir Crit Care Med 182 2010 1426 1434
21. S. Krüger, and T. Welte Biomarkers in community-acquired pneumonia Expert Rev Respir Med 6 2012 203 214
22. C. Guertler, B. Wirz, M. Christ-Crain, W. Zimmerli, B. Mueller, and P. Schuetz Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Eur Respir J 37 2011 1439 1446
23. D.T. Huang, J.A. Kellum, J. Struck, and M.R. Rosengart Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia Chest 136 2009 823 831
24. M. Christ-Crain, N.G. Morgenthaler, D. Stolz, C. Müller, R. Bingisser, and S. Harbarth et al. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia Crit Care 10 2006 R96
25. S. Bello, A.B. Lasierra, E. Mincholé, S. Fandos, M.A. Ruiz, and E. Vera et al. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology Eur Respir J 39 2012 1144 1155
26. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 2005 1823 1829
27. P. Herrero, D. Fernández, J.J. Gil, B. Prieto, J. Vázquez, and D. Miguel et al. Estudio piloto de la utilidad de la región medial de la proadrenomedulina (RM-proADM) en la valoración de la disnea de origen respiratorio en urgencias Emergencias 24 2012 357 365
28. W.C. Albrich, F. Dusemund, K. Rüegger, M. Christ-Crain, W. Zimmerli, and T. Bregenzer et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm BMC Infect Dis 11 2011 1 12
29. A. Julián-Jiménez, M.J. Palomo, J.G. Sentenac, and J. Aguilar Utilidad de la procalcitonina y la proteína C reactiva en la neumonía adquirida en la comunidad en urgencias Enferm Infecc Microbiol Clin 28 2010 666 667
30. M. Ip, T.H. Rainer, N. Lee, C. Chan, S.S. Chau, and W. Leung et al. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections Diagn Microbiol Infect Dis 59 2007 131 136
31. C. Prat, J. Domínguez, F. Andreo, S. Blanco, A. Pallares, and F. Cuchillo et al. Procalcitonin and neopterin correlation with aetiology and severity of pneumonia J Infect 52 2006 169 177
32. N. Boussekey, O. Leroy, S. Alfandari, P. Devos, H. Georges, and G. Benoit Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia Intensive Care Med 32 2006 469 472
33. A. Julián, M.J. Palomo, R. Ortiz, A. Pedrosa, R. Parejo, and R. Salcedo Utilidad de la procalcitonina y la proteína C reactiva en el paciente con sepsis en urgencias Emergencias 21 2009 23 27
34. D.T. Huang, L.A. Weissfeld, J.A. Kellum, D.M. Yealy, L. Kong, and M. Martino et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia Ann Emerg Med 52 2008 48 58
35. S. Krüger, S. Ewig, R. Marre, J. Papassotiriou, K. Richter, and H. Von Baum et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes Eur Respir J 31 2008 349 355
36. P. Schuetz, W. Albrich, and B. Mueller Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future BMC Medicine 9 2011 107
37. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, and R. Jaeschke et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 2008 296 327
38. C. León, L. García-Castrillo, M. Moya, A. Artigas, M. Borges, and F.J. Candel et al. Documento de consenso (SEMES-SEMICYUC). Recomendaciones del manejo diagnóstico-terapéutico inicial y multidisciplinario de la sepsis grave en los Servicios de Urgencias Hospitalarios Med Intensiva 31 2007 375 387
39. G.M. Vail, Y.J. Xie, D.J. Haney, and C.J. Barnes Biomarkers of thrombosis, fibrinolysis, and inflammation in patients with severe sepsis due to community-acquired pneumonia with and without Streptococcus pneumoniae Infection 37 2009 358 364
40. M.J. Fine, T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld, and D.E. Singer et al. A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250
41. W.S. Lim, M.M. van der Eerden, R. Laing, W.G. Boersma, N. Karalus, and G.I. Town et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study Thorax 58 2003 377 382
42. M.M. Levy, M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, and D. Cook et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference" Intensive Care Med 29 2003 530 538
43. M. Charlson, P. Pompei, K.L. Ales, and C.R. McKenzie A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chron Dis 40 1987 373 383
44. J. Gómez Jiménez Sistema Español de Triaje: grado de implantación y posibilidades de desarrollo futuras Emergencias 23 2011 344 345
45. E.A. Halm, and A.S. Teirstein Management of community acquired pneumonia N Engl J Med 347 2002 2039 2045
46. J.A. Hanley, and B.J. McNeil A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 1983 839 843
47. C. Ferré, F. Llopis, J. Jacob, A. Juan, X. Palom, and I. Bardés et al. Evaluación de la utilidad de la tinción de Gram del esputo para el manejo de la neumonía en urgencias Emergencias 23 2011 108 111